Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Dragonfly Therapeutics
Adaptimmune
Merck Sharp & Dohme LLC
Boehringer Ingelheim
SN BioScience
Cue Biopharma
Boehringer Ingelheim
Varian, a Siemens Healthineers Company
Kura Oncology, Inc.
I-Mab Biopharma US Limited
Incyte Corporation
Adlai Nortye Biopharma Co., Ltd.
Aptar Digital Health
PDS Biotechnology Corp.
BioAtla, Inc.
Hookipa Biotech GmbH
Hookipa Biotech GmbH
Genexine, Inc.
Palleon Pharmaceuticals, Inc.
Incyte Corporation
MacroGenics
Delfi Diagnostics Inc.
Incyte Corporation
Merck Sharp & Dohme LLC
Genentech, Inc.
Bristol-Myers Squibb
Bristol-Myers Squibb
Celldex Therapeutics
Hoffmann-La Roche
Alume Biosciences, Inc.
Revolution Medicines, Inc.
GeoVax, Inc.
Labcorp Corporation of America Holdings, Inc
Intensity Therapeutics, Inc.
PureTech
Varian, a Siemens Healthineers Company
BioAtla, Inc.
Cyteir Therapeutics, Inc.
BeiGene
Taproot Health
Jacobio Pharmaceuticals Co., Ltd.
Acepodia Biotech, Inc.
EpicentRx, Inc.
Jacobio Pharmaceuticals Co., Ltd.
Purple Biotech Ltd.
MuReva Phototherapy Inc.
Compugen Ltd
Kura Oncology, Inc.
Xencor, Inc.